Compounds > threonine

threonine and HIV Coinfection

threonine has been researched along with HIV Coinfection in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's4 (50.00)29.6817
2010's1 (12.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Ali, A; Banerjea, AC; Das, A; Mishra, R; Raja, R; Wang, C1
Berlioz-Torrent, C; Lasserre, A; Margottin-Goguet, F; Matkovic, R; Morel, M; Vauthier, V; Versapuech, M; Zamborlini, A1
Fordyce, J; García, AA; Harrison, ML; Rock, J; Wolfe, AS; Zuñiga, JA1
Bregenzer, T; Hergersberg, M; Hohenstein, E; Huber, AR; Itin, P; Rady, PL; Streit, M; Tyring, SK1
Del Valle, L; Griffiths, KO; Husain, M; Kumar, D; Malhotra, A; Mathieson, PW; Meggs, LG; Mikulak, J; Pina-Oviedo, S; Reiss, K; Saleem, MA; Seshan, SV; Simoes, S; Singhal, PC; Vashistha, H; Wang, JY1
Albrecht, H; Bocchino, M; Cervasi, B; Costantini, A; Galati, D; Magnani, M; Montroni, M; Paiardini, M; Piedimonte, G; Silvestri, G1
Tuma, RS1
Back, NK; Berkhout, B; Boucher, CA; Keulen, W; van Wijk, A1

Other Studies

8 other study(ies) available for threonine and HIV Coinfection

ArticleYear
Host AKT-mediated phosphorylation of HIV-1 accessory protein Vif potentiates infectivity via enhanced degradation of the restriction factor APOBEC3G.
    The Journal of biological chemistry, 2022, Volume: 298, Issue:4

    Topics: APOBEC-3G Deaminase; HIV Infections; HIV-1; Humans; Phosphorylation; Protein Stability; Proto-Oncogene Proteins c-akt; Threonine; vif Gene Products, Human Immunodeficiency Virus

2022
HUSH-mediated HIV silencing is independent of TASOR phosphorylation on threonine 819.
    Retrovirology, 2022, 10-29, Volume: 19, Issue:1

    Topics: HIV Infections; HIV-1; Humans; Monomeric GTP-Binding Proteins; Nocodazole; Nuclear Proteins; Phosphorylation; SAM Domain and HD Domain-Containing Protein 1; Threonine; Viral Regulatory and Accessory Proteins; Virus Latency

2022
The additive effect of type 2 diabetes on fibrinogen, von Willebrand factor, tryptophan and threonine in people living with HIV.
    Amino acids, 2019, Volume: 51, Issue:5

    Topics: Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; HIV; HIV Infections; Humans; Male; Middle Aged; Risk Factors; Threonine; Tryptophan; von Willebrand Factor

2019
Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene.
    Dermatology (Basel, Switzerland), 2009, Volume: 218, Issue:2

    Topics: Adult; AIDS-Related Opportunistic Infections; Alanine; Epidermodysplasia Verruciformis; Female; HIV Infections; Homozygote; Humans; Immunocompromised Host; Membrane Proteins; Mutation; Papillomaviridae; Polymorphism, Single Nucleotide; Threonine

2009
Inhibition of p66ShcA longevity gene rescues podocytes from HIV-1-induced oxidative stress and apoptosis.
    The Journal of biological chemistry, 2009, Jun-12, Volume: 284, Issue:24

    Topics: Active Transport, Cell Nucleus; Apoptosis; Carrier Proteins; Cell Adhesion Molecules, Neuronal; Cell Line, Transformed; Forkhead Box Protein O3; Forkhead Transcription Factors; Green Fluorescent Proteins; HIV Infections; HIV-1; Humans; Membrane Proteins; Oxidative Stress; Phenotype; Phosphorylation; Podocytes; Reactive Oxygen Species; RNA, Small Interfering; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Threonine; Transfection

2009
Specific changes in the posttranslational regulation of nucleolin in lymphocytes from patients infected with human immunodeficiency virus.
    The Journal of infectious diseases, 2003, Nov-15, Volume: 188, Issue:10

    Topics: Apoptosis; Blotting, Western; CDC2 Protein Kinase; Cell Cycle; Concanavalin A; Cyclin B; Cyclin B1; HIV Infections; HIV-1; Humans; Interleukin-2; Lymphocyte Activation; Microscopy, Confocal; Nucleolin; Phosphoproteins; Phosphorylation; Precipitin Tests; Protein Processing, Post-Translational; RNA-Binding Proteins; T-Lymphocyte Subsets; T-Lymphocytes; Threonine

2003
With targeted drugs, chronic myelogenous leukemia therapy may follow HIV's model.
    Journal of the National Cancer Institute, 2007, Feb-07, Volume: 99, Issue:3

    Topics: Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Benzamides; Dasatinib; Drug Administration Schedule; Drug Costs; Fusion Proteins, bcr-abl; HIV Infections; Humans; Imatinib Mesylate; Isoleucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Threonine; United States

2007
Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase.
    Journal of virology, 1997, Volume: 71, Issue:4

    Topics: Anti-HIV Agents; Genetic Variation; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Threonine

1997